Treatment for Interstitial Lung Disease

Not only does rheumatoid arthritis (RA) affect the joints, but it can also lead to complications of other organs, including the lungs. Rheumatoid arthritis is an autoimmune condition characterized by progressive deterioration of body joints. Interstitial lung disease (ILD) is the most common type of lung condition that can develop as a result of severe RA. The condition is characterized by scarring of lung tissue, which leads to difficulty getting an adequate amount of oxygen to the bloodstream. Symptoms of ILD include a cough and difficulty breathing. There may not be any symptoms during the early stages of ILD. During the late stages, respiratory failure may occur. The condition is diagnosed by a combination of assessment of symptoms, tests to assess lung function, and a special type of computed tomography (CT) scan.

It is essential for smokers to quit smoking, because smoking is a risk factor for ILD that is preventable. Prednisolone (Orapred) is a glucocorticoid that may be prescribed as initial treatment for ILD. This medication works to decrease inflammation and also suppresses the immune system. Cyclophosphamide and azathioprine (Imuran) are immunosuppressive medications that may be taken at the same time as prednisolone for the treatment of ILD.